Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

MYH2-associated myopathy caused by novel compound heterozygous mutations: a case report and literature review

Abstract

MYH2-associated myopathy is a group of congenital heterogeneous diseases. Case reports with MYH2-associated myopathy due to compound heterozygous mutations are rare. We report a 63-year-old Asian female who presented with bilateral ptosis and limb weakness for over 10 years. The orbits magnetic resonance imaging showed no abnormalities. Muscle biopsy revealed characteristics consistent with congenital neuromuscular disease with uniform type 1 fibers. Genetic testing identified compound heterozygous mutations in the MYH2 gene: a heterozygous mutation in exon 30, c.4066G>T (chr17:10430037, p.E1356X) and a heterozygous mutation in exon 38, c.5473-1G>A (chr17:10426730, splicing). The novel gene mutations are considered potential pathogenic variants. MYH2-associated myopathy was diagnosed. Following treatment with cytidine diphosphate choline, coenzyme Q10, methylcobalamin, and idebenone, her ocular symptoms showed slight improvement before discharge. This case highlights the importance of genetic testing in diagnosing rare myopathies and expands the genetic spectrum of MYH2-associated myopathy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Pathological findings of muscle biopsy from the left deltoid muscle.

Data availability

The data supporting this study’s findings are available from the corresponding author [Lu Guo] upon reasonable request.

References

  1. Morales PN, Coons AN, Koopman AJ, Patel S, Chase PB, Parvatiyar MS, et al. Post-translational modifications of vertebrate striated muscle myosin heavy chains. Cytoskeleton. 2024;81:832–42.

    Article  CAS  PubMed  Google Scholar 

  2. Xu WM, Gorman PA, Rider SH, Hedge PJ, Moore G, Prichard C, et al. Construction of a genetic map of human chromosome 17 by use of chromosome-mediated gene transfer. Proc Natl Acad Sci USA. 1988;85:8563–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Martinsson T, Darin N, Kyllerman M, Oldfors A, Hallberg B, Wahlström J. Dominant hereditary inclusion-body myopathy gene (IBM3) maps to chromosome region 17p13.1. Am J Hum Genet. 1999;64:1420–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Findlay AR, Harms MB, Pestronk A, Weihl CC. Homozygous recessive MYH2 mutation mimicking dominant MYH2 associated myopathy. Neuromuscul Disord. 2018;28:675–9.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Cabrera-Serrano M, Fabian VA, Boutilier J, Wise C, Faiz F, Lamont PJ, et al. Adult onset distal and proximal myopathy with complete ophthalmoplegia associated with a novel de novo p.(Leu1877Pro) mutation in MYH2. Clin Genet. 2015;88:573–8.

    Article  CAS  PubMed  Google Scholar 

  6. Baskar D, Vengalil S, Nashi S, Bardhan M, Srivastava K, Sanka SB, et al. MYH2-related myopathy: expanding the clinical spectrum of chronic progressive external ophthalmoplegia (CPEO). J Neuromuscul Dis. 2023;10:727–30.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Telese R, Pagliarani S, Lerario A, Ciscato P, Fagiolari G, Cassandrini D, et al. MYH2 myopathy, a new case expands the clinical and pathological spectrum of the recessive form. Mol Genet Genom Med. 2020;8:e1320.

    Article  CAS  Google Scholar 

  8. Sonne A, Peverelli L, Hernandez-Lain A, Domínguez-González C, Andersen JL, Milone M, et al. Myosin post-translational modifications and function in the presence of myopathy-linked truncating MYH2 mutations. Am J Physiol Cell Physiol. 2023;324:C769–C76.

    Article  CAS  PubMed  Google Scholar 

  9. Tajsharghi H, Thornell LE, Darin N, Martinsson T, Kyllerman M, Wahlström J, et al. Myosin heavy chain IIa gene mutation E706K is pathogenic and its expression increases with age. Neurology. 2002;58:780–6.

    Article  CAS  PubMed  Google Scholar 

  10. Tajsharghi H, Darin N, Rekabdar E, Kyllerman M, Wahlström J, Martinsson T, et al. Mutations and sequence variation in the human myosin heavy chain IIa gene (MYH2). Eur J Hum Genet. 2005;13:617–22.

    Article  CAS  PubMed  Google Scholar 

  11. Lossos A, Baala L, Soffer D, Averbuch-Heller L, Dotan S, Munnich A, et al. A novel autosomal recessive myopathy with external ophthalmoplegia linked to chromosome 17p13.1-p12. Brain. 2005;128:42–51.

    Article  PubMed  Google Scholar 

  12. Tajsharghi H, Hilton-Jones D, Raheem O, Saukkonen AM, Oldfors A, Udd B. Human disease caused by loss of fast IIa myosin heavy chain due to recessive MYH2 mutations. Brain. 2010;133:1451–9.

    Article  PubMed  Google Scholar 

  13. D’Amico A, Fattori F, Bellacchio E, Catteruccia M, Servidei S, Bertini E. A new de novo missense mutation in MYH2 expands clinical and genetic findings in hereditary myosin myopathies. Neuromuscul Disord. 2013;23:437–40.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Hernández-Laín A, Esteban-Pérez J, Montenegro DC, Domínguez-González C. Myosin myopathy with external ophthalmoplegia associated with a novel homozygous mutation in MYH2. Muscle Nerve 2017;55:E8–E10.

  15. Chen N, Shen N, Yu Y, Chen C, Li X, Liang J, et al. Clinical remission of myopathy with MYH2 deficiency after precision medicine-developed rehabilitation: a case report. Am J Transl Res. 2018;10:3827–32.

    PubMed  PubMed Central  Google Scholar 

  16. Argov Z. Neuromuscular disorders in Israel: a model country for ethnic clusters. Neuromuscul Disord. 2019;29:269–73.

    Article  PubMed  Google Scholar 

  17. Madigan NN, Polzin MJ, Cui G, Liewluck T, Alsharabati MH, Klein CJ, et al. Filamentous tangles with nemaline rods in MYH2 myopathy: a novel phenotype. Acta Neuropathol Commun. 2021;9:79.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Hedberg-Oldfors C, Elíasdóttir Ó, Geijer M, Lindberg C, Oldfors A. Dominantly inherited myosin IIa myopathy caused by aberrant splicing of MYH2. BMC Neurol. 2022;22:428.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Carrington G, Hau A, Kosta S, Dugdale HF, Muntoni F, D’Amico A, et al. Human skeletal myopathy myosin mutations disrupt myosin head sequestration. JCI Insight 2023;8:e172322.

  20. Cassini TA, Malicdan MCV, Macnamara EF, Lehky T, Horkayne-Szakaly I, Huang Y, et al. MYH2-associated myopathy caused by a novel splice-site variant. Neuromuscul Disord. 2023;33:257–62.

    Article  PubMed  Google Scholar 

  21. Oh SJ, Danon MJ. Nonprogressive congenital neuromuscular disease with uniform type 1 fiber. Arch Neurol. 1983;40:147–50.

    Article  CAS  PubMed  Google Scholar 

  22. Pellegrini G, Barbieri S, Moggio M, Cheldi A, Scarlato G, Minetti C. A case of congenital neuromuscular disease with uniform type I fibers, abnormal mitochondrial network and jagged Z-line. Neuropediatrics. 1985;16:162–6.

    Article  CAS  PubMed  Google Scholar 

  23. Takeda S, Horigome K, Nakadai A, Oguchi K, Yanagisawa N. A case of nemaline myopathy with uniform type I fiber and unique hybrid pattern of myosin light chains. Rinsho Shinkeigaku. 1986;26:119–27.

    CAS  PubMed  Google Scholar 

  24. Jong YJ, Huang SC, Liu GC, Chiang CH. Mental retardation in congenital nonprogressive myopathy with uniform type 1 fibers. Brain Dev. 1991;13:444–6.

    Article  CAS  PubMed  Google Scholar 

  25. Araki A, Kurokawa T, Sakuragawa N, Nonaka I. Congenital neuromuscular disease with uniform type 1 fibers : a case report. No Hattatsu. 1991;23:295–8.

    CAS  Google Scholar 

  26. Jung EY, Hattori H, Higuchi Y, Mitsuyoshi I, Kanda T. Brain atrophy in congenital neuromuscular disease with uniform type 1 fibers. Pediatr Neurol. 1997;16:56–8.

    Article  CAS  PubMed  Google Scholar 

  27. Tojo M, Ozawa M, Nonaka I. Central core disease and congenital neuromuscular disease with uniform type 1 fibers in one family. Brain Dev. 2000;22:262–4.

    Article  CAS  PubMed  Google Scholar 

  28. Sewry CA, Müller C, Davis M, Dwyer JSM, Dove J, Evans G, et al. The spectrum of pathology in central core disease. Neuromuscul Disord. 2002;12:930–8.

    Article  CAS  PubMed  Google Scholar 

  29. Na S-J, Kang S-W, Lee K-O, Lee K-Y, Kim T-S, Choi Y-C. A case of congenital neuromuscular disease with uniform type 1 fiber. Yonsei Med J. 2004;45:150–2.

    Article  PubMed  Google Scholar 

  30. Rakocevic-Stojanovic V, Lavrnic D, Nestorovic B, Dozic S, Cvetkovic D. Congenital myopathy with uniform type 1 fibers. Acta Myol. 2005;24:162–3.

    CAS  PubMed  Google Scholar 

  31. Sakamoto HM, Yoshioka M, Tsuji M, Kuroki S, Higuchi Y, Nonaka I, et al. A case of congenital neuromuscular disease with uniform type 1 fibers. Brain Dev. 2006;28:202–5.

    Article  PubMed  Google Scholar 

  32. Sato I, Wu S, Ibarra MCA, Hayashi YK, Fujita H, Tojo M, et al. Congenital neuromuscular disease with uniform type 1 fiber and RYR1 mutation. Neurology. 2008;70:114–22.

    Article  CAS  PubMed  Google Scholar 

  33. Okutani R, Arashi D, Tsujii K. Anesthetic case in a child with congenital neuromuscular disease with uniform type 1 fibers (CNMDU1). J Anesth. 2010;24:797–800.

    Article  PubMed  Google Scholar 

  34. Haraki T, Yasuda T, Mukaida K, Migita T, Hamada H, Kawamoto M. Mutated p.4894 RyR1 function related to malignant hyperthermia and congenital neuromuscular disease with uniform type 1 fiber (CNMDU1). Anesth Analg. 2011;113:1461–7.

    Article  PubMed  Google Scholar 

  35. Imagama S, Kawakami N, Tsuji T, Ohara T, Ishiguro N. Kyphoscoliosis associated with congenital neuromuscular disease with uniform type 1 fibers. Eur Spine J. 2012;21:S499–S504.

    Article  PubMed  Google Scholar 

  36. Sanmaneechai O, Likasitwattanakul S, Sangruchi T, Nishino I. Ophthalmoplegia in congenital neuromuscular disease with uniform type 1 fiber. Brain Dev. 2015;37:459–62.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work is supported by the Key Clinical Specialty of Neurology of PLA to Daping Hospital.

Funding

This study was supported by the Natural Science Foundation Project of CQ CSTC (cstc2019jscx-msxmX0285) and the Natural Science Foundation Project of Chongqing (CSTB2022NSCQ-MSX1585).

Author information

Authors and Affiliations

Authors

Contributions

Yulai Kang, Tong Yang and Xue Chen wrote the manuscript. Zhuo Min and Chunhua Tang diagnosed, treated, and followed the patient. Lili Zhang and Lu Guo conceived the study and revised it critically for important intellectual content. All authors read and approved the final version of the manuscript.

Corresponding authors

Correspondence to Lili Zhang or Lu Guo.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

This study was exempted from ethical applications by the ethics committee of the Army Medical Centre of PLA. Written informed consent was obtained from the patient.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kang, Y., Yang, T., Chen, X. et al. MYH2-associated myopathy caused by novel compound heterozygous mutations: a case report and literature review. J Hum Genet 70, 655–659 (2025). https://doi.org/10.1038/s10038-025-01400-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s10038-025-01400-7

Search

Quick links